World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
36716
World Ranking
9598
National Ranking
4943

Overview

Edward P. Gelmann is affiliated with the University of Arizona in the United States. Their research primarily focuses on medicine, with significant contributions to pulmonary and respiratory medicine, oncology, epidemiology, genetics, and molecular biology. The main topics of their work include prostate cancer treatment and research, renal cell carcinoma treatment, cancer immunotherapy and biomarkers, neuroendocrine tumor research advances, neuroblastoma research and treatments, lung cancer research studies, and estrogen-related hormone effects.

The scientist has contributed to several recent publications, including:

  • Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors (2024) - The Oncologist
  • Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer (2022) - Cancer Medicine
  • CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss (2020) - Cancer Research
  • A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with advanced or metastatic renal cell carcinoma (2025) - Journal of Clinical Oncology
  • The expanding role of hormones in cancer (2021) - Endocrine Oncology

Edward P. Gelmann frequently publishes in the following venues:

  • Journal of Clinical Oncology (3 publications)
  • Cancer Research (2 publications)
  • The Oncologist (1 publication)
  • Cancer Medicine (1 publication)
  • Endocrine Oncology (1 publication)

The scientist collaborates regularly with several coauthors, including:

  • Bilal A. Siddiqui
  • Benedito A. Carneiro
  • Mark N. Stein
  • Jingsong Zhang
  • David R. Wise

Overall, Edward P. Gelmann's work intersects multiple subfields of medicine, with a strong emphasis on cancer research and hormonal effects related to oncological conditions.

Best Publications

  • Mortality Results from a Randomized Prostate-Cancer Screening Trial

    Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys

  • Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

    Robert C. Gallo;Prem S. Sarin;E. P. Gelmann;Marjorie Robert-Guroff

  • Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

    Meredith Yeager;Nick Orr;Richard B Hayes;Kevin B Jacobs

  • Molecular Biology of the Androgen Receptor

    Edward P. Gelmann

  • Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations

    A S Fauci;A M Macher;D L Longo;H C Lane

  • Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

    Philip C Prorok;Gerald L Andriole;Robert S. Bresalier;Saundra S Buys

  • ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

    Robert Yarchoan;Kent J. Weinhold;H. Kim Lyerly;Edward Gelmann

  • Cryptococcosis in the acquired immunodeficiency syndrome.

    Joseph A. Kovacs;Andrea A. Kovacs;Michael Polis;W. Craig Wright

  • Expression of cellular homologues of retroviral onc genes in human hematopoietic cells

    E H Westin;F Wong-Staal;E P Gelmann;R Dalla-Favera

  • The Ubiquitin-Proteasome Pathway and Its Role in Cancer

    Aparna Mani;Edward P. Gelmann

  • Physical properties of membrane lipids: biological relevance and regulation.

    J E Cronan;E P Gelmann

  • Malignant Pheochromocytoma: Effective Treatment with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine

    Steven D. Averbuch;Caryn S. Steakley;Robert C. Young;Edward P. Gelmann

  • Loss of NKX3.1 Expression in Human Prostate Cancers Correlates with Tumor Progression1,2

    Cai Bowen;Lukas Bubendorf;H. James Voeller;Rebecca Slack

  • A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.

    W W He;P J Sciavolino;J Wing;M Augustus

  • β-Catenin Mutations in Human Prostate Cancer

    H J Voeller;C I Truica;E P Gelmann

  • Autocrine and paracrine growth regulation of human breast cancer

    Marc E. Lippman;Robert B. Dickson;Susan Bates;Cornelius Knabbe

  • β-Catenin Affects Androgen Receptor Transcriptional Activity and Ligand Specificity

    Cristina I. Truica;Stephen Byers;Edward P. Gelmann

  • Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

    R Dalla-Favera;E P Gelmann;S Martinotti;G Franchini

  • The Acquired Immunodeficiency Syndrome: An Update

    Fauci As;Masur H;Gelmann Ep;Markham Pd

  • Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

    Adam S. Kibel

Frequent Co-Authors

Henry Masur
Henry Masur National Institutes of Health
Robert C. Gallo
Robert C. Gallo University of South Florida
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Marc E. Lippman
Marc E. Lippman National Institutes of Health
Flossie Wong-Staal
Flossie Wong-Staal University of California, San Diego
Paul F. Pinsky
Paul F. Pinsky National Institutes of Health
Gerald L. Andriole
Gerald L. Andriole Washington University in St. Louis
Lukas Bubendorf
Lukas Bubendorf University Hospital of Basel
David Chia
David Chia University of California, Los Angeles
Barnett S. Kramer
Barnett S. Kramer National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine can open doors to diverse allied health fields. Many students are searching for flexible options and alternative pathways to build their future in healthcare without following a traditional MD route.

For instance, aspiring nurses can enroll in absn programs that don't require teas, avoiding standardized test requirements and accelerating their journey to becoming an RN. Another in-demand choice is pursuing online health administration programs, perfect for those interested in management and leadership roles within medical organizations.

Registered nurses seeking career advancement can bridge their current qualification with specialized practice by enrolling in an rn to np bridge program. These programs are designed for working professionals and are often delivered in a hybrid or online format.

Additionally, nutrition-focused students can consider an online dietitian degree, enabling flexible study while preparing for roles in health promotion, clinical nutrition, or wellness coaching.

Online and accelerated healthcare degrees are excellent alternatives for those looking to build fulfilling careers in medicine-related fields without attending traditional, lengthy programs.

Best Scientists Citing Edward P. Gelmann

Trending Scientists

Recently Published Articles